- Home
- MCVT vs PMCB Comparison
MCVT vs PMCB Comparison
Compare MCVT & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- PMCB
- Stock Information
- Founded
- MCVT 2007
- PMCB 1996
- Country
- MCVT United States
- PMCB United States
- Employees
- MCVT N/A
- PMCB N/A
- Industry
- MCVT Finance Companies
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCVT Finance
- PMCB Health Care
- Exchange
- MCVT Nasdaq
- PMCB Nasdaq
- Market Cap
- MCVT 14.7M
- PMCB 15.8M
- IPO Year
- MCVT N/A
- PMCB N/A
- Fundamental
- Price
- MCVT $2.13
- PMCB $1.77
- Analyst Decision
- MCVT
- PMCB
- Analyst Count
- MCVT 0
- PMCB 0
- Target Price
- MCVT N/A
- PMCB N/A
- AVG Volume (30 Days)
- MCVT 132.3K
- PMCB 37.4K
- Earning Date
- MCVT 11-15-2024
- PMCB 09-17-2024
- Dividend Yield
- MCVT N/A
- PMCB N/A
- EPS Growth
- MCVT N/A
- PMCB N/A
- EPS
- MCVT 0.04
- PMCB 0.54
- Revenue
- MCVT $3,248,401.00
- PMCB N/A
- Revenue This Year
- MCVT N/A
- PMCB N/A
- Revenue Next Year
- MCVT N/A
- PMCB N/A
- P/E Ratio
- MCVT $59.35
- PMCB $3.23
- Revenue Growth
- MCVT N/A
- PMCB N/A
- 52 Week Low
- MCVT $2.10
- PMCB $1.39
- 52 Week High
- MCVT $3.88
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- MCVT 36.04
- PMCB 48.90
- Support Level
- MCVT $2.23
- PMCB $1.72
- Resistance Level
- MCVT $2.47
- PMCB $2.06
- Average True Range (ATR)
- MCVT 0.30
- PMCB 0.28
- MACD
- MCVT -0.08
- PMCB -0.00
- Stochastic Oscillator
- MCVT 0.00
- PMCB 38.24
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.